AMLX   $5.26  1.35% Market Closed After Close 5.23 -0.57%

Amylyx Pharmaceuticals Inc
Total Cash 309.81M
totalCashPerShare 4.551
EBITDA -176.64M
Total Debt 3.14M
quickRatio 4.481
currentRatio 4.662
Total Revenue 298.76M
debtToEquity 1.202
Revenue/Share 4.412
ROA -0.28279
ROE -0.5122
grossProfits
freeCashflow -12.66M
operatingCashflow -58.69M
earningsGrowth
revenueGrowth
grossMargins 0.085200004
ebitdaMargins -0.59123003
operatingMargins 74.57087
profitMargins -0.55519
enterpriseValue 116.80M
forwardPE -3.3085105
floatShares 42.00M
sharesOutstanding 68.08M
sharesShort 1.01M
sharesShortPriorMonth 1.26M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.94%
Short Ratio help_outline 0.76%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 3.838
Price To Book help_outline 1.62
earningsQuarterlyGrowth
netIncomeToCommon -165.87M
trailingEps -2.46%
forwardEps -1.88%
enterpriseToEbitda -0.66
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.71 3Q 2024
institutionsCount 168
lastUpdated Nov. 7, 2024, 11:01 a.m.